Lung Transplantation - Pipeline Review, H1 2015

02:29 EDT 22 Jul 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Lung Transplantation - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-06-16. This 47-page report is available in PDF from $2000.

Lung Transplantation - Pipeline Review, H1 2015


Global Markets Direct’s, ‘Lung Transplantation - Pipeline Review, H1 2015’, provides an overview of the Lung Transplantation’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Lung Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lung Transplantation and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides a snapshot of the global therapeutic landscape of Lung Transplantation
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Lung Transplantation and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Lung Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Lung Transplantation pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of…

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Lung Transplantation Overview 6
Therapeutics Development 7
Pipeline Products for Lung Transplantation - Overview 7
Pipeline Products for Lung Transplantation - Comparative Analysis 8
Lung Transplantation - Therapeutics under Development by Companies 9
Lung Transplantation - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Lung Transplantation - Products under Development by Companies 12
Lung Transplantation - Companies Involved in Therapeutics Development 13
Kamada Ltd. 13
Proteo, Inc. 14
Quark Pharmaceuticals, Inc. 15
Lung Transplantation - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Target 17
Assessment by Mechanism of Action 19
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
alpha-1 proteinase inhibitor (human) - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Elafin - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
FX-06 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
R-503 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
R-801 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Recombinant Human Follistatin - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
RNAi Oligonucleotide for Lung Diseases - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Lung Transplantation - Recent Pipeline Updates 38
Lung Transplantation - Dormant Projects 43
Lung Transplantation - Product Development Milestones 44
Featured News & Press Releases 44
Mar 12, 2015: Elafin combined with cyclosporine promises to overcome limitations of cyclosporine for preventing irreversible damage to transplanted organs 44
Dec 06, 2011: Proteo And Its Subsidiary Announce Major Advances In Elafin Development Program 44
Appendix 46
Methodology 46
Coverage 46
Secondary Research 46
Primary Research 46
Expert Panel Validation 46
Contact Us 46
Disclaimer 47

For more information open Lung Transplantation - Pipeline Review, H1 2015.


Original Article: Lung Transplantation - Pipeline Review, H1 2015


More From BioPortfolio on "Lung Transplantation - Pipeline Review, H1 2015"

Quick Search


Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...